Korean botulinum toxin will conquer the European market
Korean botulinum toxin will conquer the European market
  • Cho Eun, Reporter
  • 승인 2024.06.20 17:06
  • 수정 2024.06.20 17:06
  • 댓글 0
이 기사를 공유합니다

Daewoong Pharmaceutical "Nusiva Landing in Spain...Expanding 5 European Countries"

Daewoong Pharmaceutical announced the entry of its own botulinum toxin preparation into Spain through its partner Evolus on the 19th.

The product name to be sold in Europe is 'Nushiva'.

As a result, Daewoong Pharmaceutical's botulinum toxin has expanded its scope to a total of five countries, including the UK, Germany, Austria, and Italy, which are major European markets.

Europe is the second largest botulinum toxin market after the United States, according to global market research firm Fortune Business Insights (FBI).

Spain is one of the leading aesthetic markets in Europe. Five countries in the European market, including Spain, the UK, Germany, Italy, and Austria, account for about 70% of the total market.

"We have started operating directly in Spain, one of Europe's largest beauty markets, to expand our business to markets around the world, including Europe," said David Moatajedi, CEO of Evolus. "We will continue to grow in the field of beauty toxin through Nusiva's successful settlement in Spain."

"We expect that Nusiva's influence in Europe will expand in earnest as it enters the Spanish market, which has great growth potential," said Park Sung-soo, president of Daewoong Pharmaceutical. "We plan to continue expanding our overseas expansion, with additional overseas markets such as Ireland and Australia scheduled to enter by the end of the year."

[WIKI KOREA=Cho Eun, Reporter]


기자가 쓴 기사

  • 서울특별시 마포구 마포대로 127, 1001호 (공덕동, 풍림빌딩)
  • 대표전화 : 02-702-2677
  • 팩스 : 02-702-1677
  • 청소년보호책임자 : 소정원
  • 법인명 : 위키리크스한국 주식회사
  • 제호 : 위키리크스한국
  • 등록번호 : 서울 아 04701
  • 등록일 : 2013-07-18
  • 발행일 : 2013-07-18
  • 발행인 : 박정규
  • 편집인 : 박찬흥
  • 위키리크스한국은 자체 기사윤리 심의 전문위원제를 운영합니다.
  • 기사윤리 심의 : 박지훈 변호사
  • 위키리크스한국 모든 콘텐츠(영상,기사, 사진)는 저작권법의 보호를 받은바, 무단 전재와 복사, 배포 등을 금합니다.
  • Copyright © 2024 위키리크스한국. All rights reserved.
  • [위키리크스한국 보도원칙] 본 매체는 독자와 취재원 등 뉴스 이용자의 권리 보장을 위해 반론이나 정정보도, 추후보도를 요청할 수 있는 창구를 열어두고 있음을 알립니다.
    고충처리 : 02-702-2677 | 메일 : laputa813@wikileaks-kr.org